Page last updated: 2024-08-16

pindolol and fluoxetine

pindolol has been researched along with fluoxetine in 54 studies

Research

Studies (54)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	27 (50.00)	18.2507
2000's	19 (35.19)	29.6817
2010's	8 (14.81)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Caron, G; Ermondi, G	1
Morphy, R; Rankovic, Z	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Abraham, MH; Acree, WE; Ibrahim, A	1
Ahman, M; Holmén, AG; Wan, H	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Janowsky, DS; Overstreet, DH; Rezvani, AH	1
Bourson, A; Carolo, C; Petit, N; Sleight, AJ; Zwingelstein, C	1
Hietala, J; Kuoppamäki, M; Laakso, A; Pälvimäki, EP; Syvälahti, E	1
Paré, WP; Tejani-Butt, SM; Yang, J	1
Tejani-Butt, SM; Yang, J	1
Dreshfield, LJ; Engleman, EA; Perry, KW; Wong, DT	1
Koran, LM; Maloney, A; Mueller, K	1
Bril, T; Demedts, P; Maes, M; Neels, H; Van de Vyvere, J; Vandoolaeghe, E; Wauters, A	1
Desnyder, R; Maes, M; Vandoolaeghe, E	1
Anand, A; Berman, RM; Charney, DS; Darnell, AM; Miller, HL	1
Demedts, P; Maes, M; Neels, H; Van Hunsel, F; Vandoolaeghe, E; Wauters, A	1
Alvarez, E; Artigas, F; Faries, D; Gilaberte, I; Pérez, V	1
Bordet, R; Dupuis, B; Thomas, P	1
Terao, T	1
Dreshfield, LJ; Rocco, VP; Wong, DT	1
Demedts, P; Maes, M; Meltzer, HY; Neels, H; Vandoolaeghe, E; Wauters, A; Westenberg, H	1
Paré, WP; Tejani-Butt, SM; Zafar, HM	1
Browning, RA; Dailey, JW; Jobe, PC; Merrill, MA; Wood, AV	1
Iyengar, S; Li, DL; Simmons, RM	1
Lin, A; Maes, M; Scharpé, S; Vandoolaeghe, E; Verkerk, R	1
Alvarez, E; Artigas, F; Pérez, V; Puigdemont, D; Soler, J	1
Campens, D; Libbrecht, I; Maes, M; Meltzer, HY; van Hunsel, F	1
Anand, A; Berman, RM; Cappiello, A; Charney, DS; Hu, XS; Miller, HL; Oren, DA	1
Moser, PC; Sanger, DJ	1
Hirao, N; Koshino, Y; Nakamura, M; Shiraishi, J; Wada, Y	1
Gobert, A; Millan, MJ	1
Fornal, CA; Jacobs, BL; Martin, FJ; Metzler, CW	1
Dawson, LA; Nguyen, HQ	1
Alvarez, E; Artigas, F; Boto, B; Buesching, DP; Demitrack, M; Gilaberte, I; Obenchain, RL; Pérez Sola, V; Sacristán, JA	1
Dawson, LA; Nguyen, HQ; Schechter, LE; Smith, DI	1
Faries, DE; Feng, J; Tamura, RN	1
Broft, A; Laruelle, M; Martinez, D	1
Alvarez, E; Artigas, F; Gilaberte, I; Pérez, V; Puiigdemont, D	1
Cremaschi, GA; Edgar, VA; Genaro, AM; Sterin-Borda, L	1
McCreary, AC; Rasmussen, K; Shanks, EA	1
Anand, A; Berman, RM; Charney, DS; Lynch-Colonese, K; Perry, EB; Sanacora, G	1
Anjaneyulu, M; Chopra, K	1
Albert, PR; Bakish, D; Du, L; Hrdina, P; Lemonde, S	1
Alvarez, E; de Diego-Adeliño, J; Pérez, V; Pérez-Egea, R; Portella, MJ; Puigdemont, D	1
Alvarez, E; Artigas, F; de Diego-Adeliño, J; Pérez, V; Pérez-Egea, R; Portella, MJ; Puigdemont, D	1
Bregman, T; Diwan, M; Fletcher, PJ; Hamani, C; Nobrega, JN; Raymond, R; Scott, B; Volle, J	1

Reviews

3 review(s) available for pindolol and fluoxetine

Article	Year
Designed multiple ligands. An emerging drug discovery paradigm. Journal of medicinal chemistry, 2005, Oct-20, Volume: 48, Issue:21 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Antihypertensive Agents; Antipsychotic Agents; Chemistry, Pharmaceutical; Dopamine D2 Receptor Antagonists; Drug Design; Humans; Ligands; Metabolic Diseases; Peroxisome Proliferator-Activated Receptors; Receptors, Histamine H1; Selective Serotonin Reuptake Inhibitors	2005
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Pindolol augmentation of antidepressant treatment: recent contributions from brain imaging studies. Biological psychiatry, 2000, Oct-15, Volume: 48, Issue:8 Topics: Animals; Brain; Cerebrovascular Circulation; Clinical Trials as Topic; Depressive Disorder, Major; Drug Synergism; Fluoxetine; Humans; Paroxetine; Pindolol; Rats; Selective Serotonin Reuptake Inhibitors; Tomography, Emission-Computed	2000

Trials

15 trial(s) available for pindolol and fluoxetine

Article	Year
Alterations in iron metabolism and the erythron in major depression: further evidence for a chronic inflammatory process. Journal of affective disorders, 1996, Sep-09, Volume: 40, Issue:1-2 Topics: Acute-Phase Reaction; Adrenergic beta-Antagonists; Adult; Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Erythrocyte Count; Erythrocyte Indices; Female; Ferritins; Fluoxetine; Hematocrit; Hemoglobinometry; Humans; Iron; Male; Middle Aged; Pindolol; Transferrin; Trazodone	1996
Efficacy of treatment with trazodone in combination with pindolol or fluoxetine in major depression. Journal of affective disorders, 1996, Dec-16, Volume: 41, Issue:3 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Personality Inventory; Pindolol; Serotonin Antagonists; Trazodone	1996
Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trial. The American journal of psychiatry, 1997, Volume: 154, Issue:1 Topics: Adolescent; Adult; Aged; Ambulatory Care; Depressive Disorder; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Pindolol; Placebos; Treatment Outcome	1997
Lower total serum protein, albumin, and beta- and gamma-globulin in major and treatment-resistant depression: effects of antidepressant treatments. Psychiatry research, 1996, Dec-20, Volume: 65, Issue:3 Topics: Acute-Phase Proteins; Adrenergic beta-Antagonists; Adult; Aged; Alpha-Globulins; Antidepressive Agents, Second-Generation; Beta-Globulins; Depressive Disorder; Drug Synergism; Drug Therapy, Combination; Female; Fluoxetine; gamma-Globulins; Humans; Male; Middle Aged; Pindolol; Serum Albumin; Trazodone; Treatment Failure	1996
Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment. Lancet (London, England), 1997, May-31, Volume: 349, Issue:9065 Topics: Adult; Antidepressive Agents, Second-Generation; Depression; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Pindolol; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome	1997
Effects of trazodone and fluoxetine in the treatment of major depression: therapeutic pharmacokinetic and pharmacodynamic interactions through formation of meta-chlorophenylpiperazine. Journal of clinical psychopharmacology, 1997, Volume: 17, Issue:5 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Personality Inventory; Pindolol; Piperazines; Trazodone; Treatment Outcome	1997
Serum levels of excitatory amino acids, serine, glycine, histidine, threonine, taurine, alanine and arginine in treatment-resistant depression: modulation by treatment with antidepressants and prediction of clinical responsivity. Acta psychiatrica Scandinavica, 1998, Volume: 97, Issue:4 Topics: Adult; Aged; Alanine; Antidepressive Agents; Antidepressive Agents, Tricyclic; Arginine; Asparagine; Aspartic Acid; Depressive Disorder, Major; Drug Resistance; Drug Therapy, Combination; Excitatory Amino Acids; Female; Fluoxetine; Glycine; Histidine; Humans; Male; Middle Aged; Personality Inventory; Pindolol; Prognosis; Selective Serotonin Reuptake Inhibitors; Serine; Taurine; Threonine; Trazodone; Treatment Outcome	1998
A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius. Archives of general psychiatry, 1999, Volume: 56, Issue:4 Topics: Adult; Ambulatory Care; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Pindolol; Placebos; Selective Serotonin Reuptake Inhibitors; Single-Blind Method	1999
Pindolol and mianserin augment the antidepressant activity of fluoxetine in hospitalized major depressed patients, including those with treatment resistance. Journal of clinical psychopharmacology, 1999, Volume: 19, Issue:2 Topics: Adult; Aged; Analysis of Variance; Depressive Disorder; Fluoxetine; Humans; Mianserin; Middle Aged; Pindolol; Psychiatric Status Rating Scales	1999
The use of pindolol with fluoxetine in the treatment of major depression: final results from a double-blind, placebo-controlled trial. Biological psychiatry, 1999, May-01, Volume: 45, Issue:9 Topics: Adult; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Pindolol	1999
Cost-effectiveness of fluoxetine plus pindolol in patients with major depressive disorder: results from a randomized, double-blind clinical trial. International clinical psychopharmacology, 2000, Volume: 15, Issue:2 Topics: Adult; Antidepressive Agents, Second-Generation; Cost-Benefit Analysis; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Health Care Costs; Humans; Male; Middle Aged; Pindolol; Serotonin Antagonists	2000
Augmentation of fluoxetine's antidepressant action by pindolol: analysis of clinical, pharmacokinetic, and methodologic factors. Journal of clinical psychopharmacology, 2001, Volume: 21, Issue:1 Topics: Adrenergic beta-Antagonists; Adult; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Methods; Pindolol; Survival Analysis; Treatment Outcome	2001
Pindolol augmentation in depressed patients resistant to selective serotonin reuptake inhibitors: a double-blind, randomized, controlled trial. The Journal of clinical psychiatry, 2004, Volume: 65, Issue:2 Topics: Adrenergic beta-Antagonists; Adult; Aged; Connecticut; Cross-Over Studies; Depressive Disorder, Major; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Fluoxetine; Hospitals, Veterans; Humans; Male; Middle Aged; Paroxetine; Personality Inventory; Pindolol; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Veterans	2004
A short duration of untreated illness (DUI) improves response outcomes in first-depressive episodes. Journal of affective disorders, 2010, Volume: 120, Issue:1-3 Topics: Adult; Citalopram; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Female; Fluoxetine; Humans; Male; Pindolol; Recurrence; Remission Induction; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists	2010
Pindolol augmentation enhances response outcomes in first depressive episodes. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2009, Volume: 19, Issue:7 Topics: Adolescent; Adult; Antidepressive Agents; Depression; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Humans; Kaplan-Meier Estimate; Male; Pindolol; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Treatment Outcome; Young Adult	2009

Other Studies

36 other study(ies) available for pindolol and fluoxetine

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk). Journal of medicinal chemistry, 2005, May-05, Volume: 48, Issue:9 Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water	2005
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs. European journal of medicinal chemistry, 2008, Volume: 43, Issue:3 Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization	2008
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs. Journal of medicinal chemistry, 2009, Mar-26, Volume: 52, Issue:6 Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry	2009
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10 Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection	2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Drug-induced reductions in ethanol intake in alcohol preferring and Fawn-Hooded rats. Alcohol and alcoholism (Oxford, Oxfordshire). Supplement, 1991, Volume: 1 Topics: Alcohol Drinking; Alcoholism; Animals; Buspirone; Drinking Behavior; Ethanol; Feeding Behavior; Fluoxetine; Male; Pindolol; Piperazines; Rats; Rats, Inbred Strains; Rats, Wistar; Scopolamine; Self Administration; Serotonin Receptor Agonists; Species Specificity; Verapamil	1991
Identification of 5-hydroxytryptamine7 receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment. Molecular pharmacology, 1995, Volume: 47, Issue:1 Topics: Animals; Binding Sites; Down-Regulation; Fluoxetine; Hypothalamus; Kinetics; Male; Membranes; Pindolol; Rats; Receptors, Serotonin; Sensitivity and Specificity; Serotonin; Tritium	1995
Up-regulation of beta 1-adrenergic receptors in rat brain after chronic citalopram and fluoxetine treatments. Psychopharmacology, 1994, Volume: 115, Issue:4 Topics: Adrenergic beta-1 Receptor Agonists; Animals; Autoradiography; Brain Chemistry; Citalopram; Fluoxetine; Image Processing, Computer-Assisted; Imipramine; Iodocyanopindolol; Male; Pindolol; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Up-Regulation	1994
Effect of repeated novel stressors on depressive behavior and brain norepinephrine receptor system in Sprague-Dawley and Wistar Kyoto (WKY) rats. Brain research, 1994, Jun-27, Volume: 649, Issue:1-2 Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Body Weight; Brain; Carrier Proteins; Depression; Dioxanes; Fluoxetine; Idazoxan; Male; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Pindolol; Rats; Rats, Inbred WKY; Rats, Sprague-Dawley; Receptors, Adrenergic; Species Specificity; Stress, Psychological; Swimming; Symporters	1994
A time course of altered thyroid states on the noradrenergic system in rat brain by quantitative autoradiography. Neuroendocrinology, 1994, Volume: 59, Issue:3 Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Animals; Autoradiography; Body Weight; Brain Chemistry; Dioxanes; Fluoxetine; Idazoxan; Male; Norepinephrine; Pindolol; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Presynaptic; Thyroid Gland; Thyroidectomy; Time Factors	1994
Enhancement of fluoxetine-dependent increase of extracellular serotonin (5-HT) levels by (-)-pindolol, an antagonist at 5-HT1A receptors. Neurochemical research, 1996, Volume: 21, Issue:5 Topics: Analysis of Variance; Animals; Dose-Response Relationship, Drug; Fluoxetine; Hypothalamus; Infusions, Parenteral; Kinetics; Male; Microdialysis; Pindolol; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Serotonin Antagonists	1996
Will pindolol augment the response to a serotonin reuptake inhibitor in obsessive-compulsive disorder? Journal of clinical psychopharmacology, 1996, Volume: 16, Issue:3 Topics: 1-Naphthylamine; Adrenergic beta-Antagonists; Adult; Antidepressive Agents; Clomipramine; Drug Synergism; Female; Fluoxetine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Pindolol; Selective Serotonin Reuptake Inhibitors; Sertraline	1996
Selective serotonin reuptake inhibitors plus pindolol. The REEP. Lancet (London, England), 1997, Jul-26, Volume: 350, Issue:9073 Topics: Depressive Disorder; Fluoxetine; Humans; Paroxetine; Pindolol; Selective Serotonin Reuptake Inhibitors; Sympatholytics	1997
Selective serotonin reuptake inhibitors plus pindolol. Lancet (London, England), 1997, Jul-26, Volume: 350, Issue:9073 Topics: Depressive Disorder; Drug Interactions; Fluoxetine; Humans; Pindolol; Selective Serotonin Reuptake Inhibitors; Sympatholytics	1997
Greater effects of fluoxetine and its combination with (-)-pindolol in elevating hypothalamic serotonin in rats during dark hours. The Chinese journal of physiology, 1997, Jun-30, Volume: 40, Issue:2 Topics: Adrenergic beta-Antagonists; Animals; Circadian Rhythm; Darkness; Drug Synergism; Fluoxetine; Hypothalamus; Male; Microdialysis; Pindolol; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin	1997
Effect of acute or repeated stress on behavior and brain norepinephrine system in Wistar-Kyoto (WKY) rats. Brain research bulletin, 1997, Volume: 44, Issue:3 Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Autoradiography; Behavior, Animal; Chronic Disease; Fluoxetine; Iodine Radioisotopes; Limbic System; Male; Norepinephrine; Pindolol; Rats; Rats, Inbred WKY; Restraint, Physical; Stress, Physiological; Tritium	1997
Enhancement of the anticonvulsant effect of fluoxetine following blockade of 5-HT1A receptors. European journal of pharmacology, 1997, Oct-01, Volume: 336, Issue:1 Topics: Acoustic Stimulation; Animals; Anticonvulsants; Brain; Cyclohexylamines; Drug Interactions; Female; Fenclonine; Fluoxetine; Norepinephrine; Pindolol; Rats; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Seizures; Serotonin; Serotonin Antagonists	1997
5HT1A receptor antagonists enhance the functional activity of fluoxetine in a mouse model of feeding. Brain research, 1998, Jan-19, Volume: 781, Issue:1-2 Topics: Animals; Cyclohexylamines; Drinking Behavior; Drug Synergism; Feeding Behavior; Fluoxetine; Male; Mice; Mice, Inbred Strains; Pindolol; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists	1998
5-HT1A receptor antagonists neither potentiate nor inhibit the effects of fluoxetine and befloxatone in the forced swim test in rats. European journal of pharmacology, 1999, May-14, Volume: 372, Issue:2 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Analysis of Variance; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Drug Interactions; Fluoxetine; Male; Monoamine Oxidase Inhibitors; Oxazoles; Pindolol; Piperazines; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Swimming	1999
Pindolol potentiates the effect of fluoxetine on hippocampal seizures in rats. Neuroscience letters, 1999, May-21, Volume: 267, Issue:1 Topics: Animals; Drug Synergism; Fluoxetine; Hippocampus; Male; Pindolol; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Seizures; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists	1999
Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B re Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1999, Volume: 21, Issue:2 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Betaxolol; Dopamine; Fluoxetine; Frontal Lobe; Guinea Pigs; Humans; Male; Microdialysis; Norepinephrine; Pindolol; Piperazines; Propanolamines; Pyridines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1B; Receptors, Adrenergic, beta; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists	1999
Pindolol, a putative 5-hydroxytryptamine(1A) antagonist, does not reverse the inhibition of serotonergic neuronal activity induced by fluoxetine in awake cats: comparison to WAY-100635. The Journal of pharmacology and experimental therapeutics, 1999, Volume: 291, Issue:1 Topics: Animals; Cats; Drug Interactions; Fluoxetine; Male; Neurons; Pindolol; Piperazines; Pyridines; Raphe Nuclei; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists	1999
The role of 5-HT(1A) and 5-HT(1B/1D) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of (+/-)pindolol. Neuropharmacology, 2000, Apr-03, Volume: 39, Issue:6 Topics: Animals; Autoreceptors; Drug Synergism; Extracellular Space; Fluoxetine; Male; Microdialysis; Oxadiazoles; Pindolol; Piperazines; Propanolamines; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists	2000
Effects of chronic fluoxetine treatment in the presence and absence of (+/-)pindolol: a microdialysis study. British journal of pharmacology, 2000, Volume: 130, Issue:4 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Dose-Response Relationship, Drug; Fluoxetine; Frontal Lobe; Male; Microdialysis; Pindolol; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Time Factors	2000
Comparing time to onset of response in antidepressant clinical trials using the cure model and the Cramer-von Mises test. Statistics in medicine, 2000, Aug-30, Volume: 19, Issue:16 Topics: Adrenergic beta-Antagonists; Algorithms; Antidepressive Agents; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Depressive Disorder; Fluoxetine; Humans; Models, Statistical; Pindolol; Sample Size; Statistical Distributions; Survival Analysis; Time Factors; Treatment Outcome	2000
Altered expression of autonomic neurotransmitter receptors and proliferative responses in lymphocytes from a chronic mild stress model of depression: effects of fluoxetine. Brain, behavior, and immunity, 2002, Volume: 16, Issue:4 Topics: Adrenergic beta-Antagonists; Animals; Antidepressive Agents, Second-Generation; Autonomic Nervous System; B-Lymphocytes; CD4-CD8 Ratio; Cell Division; Chronic Disease; Cyclic AMP; Cyclic GMP; Disease Models, Animal; Female; Fluoxetine; Iodine Radioisotopes; Mice; Mice, Inbred BALB C; Mitogens; Muscarinic Antagonists; Pindolol; Quinuclidinyl Benzilate; Radioligand Assay; Receptors, Adrenergic, beta; Receptors, Muscarinic; Stress, Psychological; T-Lymphocytes; Tritium	2002
Attenuation of the effects of fluoxetine on serotonergic neuronal activity by pindolol in rats. Neuroscience letters, 2004, Jan-23, Volume: 355, Issue:1-2 Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Male; Neurons; Pindolol; Pons; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Treatment Outcome	2004
Fluoxetine attenuates thermal hyperalgesia through 5-HT1/2 receptors in streptozotocin-induced diabetic mice. European journal of pharmacology, 2004, Aug-30, Volume: 497, Issue:3 Topics: Analgesics; Animals; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Fluoxetine; Hot Temperature; Hyperalgesia; Male; Mice; Ondansetron; Pindolol; Receptors, Serotonin, 5-HT1; Receptors, Serotonin, 5-HT2; Ritanserin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Streptozocin; Time Factors; Touch	2004
Association of the C(-1019)G 5-HT1A functional promoter polymorphism with antidepressant response. The international journal of neuropsychopharmacology, 2004, Volume: 7, Issue:4 Topics: Adrenergic beta-Antagonists; Adult; Alleles; Antidepressive Agents; Antidepressive Agents, Second-Generation; Benzimidazoles; Cohort Studies; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Pindolol; Piperazines; Polymorphism, Genetic; Promoter Regions, Genetic; Psychiatric Status Rating Scales; Receptor, Serotonin, 5-HT1A; Triazoles	2004
Deep brain stimulation and fluoxetine exert different long-term changes in the serotonergic system. Neuropharmacology, 2018, Volume: 135 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Brain; Deep Brain Stimulation; Fluoxetine; Hippocampus; Iodine Radioisotopes; Pindolol; Prefrontal Cortex; Radioligand Assay; Rats; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT1B; Serotonin; Serotonin Plasma Membrane Transport Proteins; Time Factors; Tritium	2018